Overexpression of ASPH protein predicts poor outcomes in retroperitoneal liposarcoma patients

Chin Med J (Engl). 2023 Sep 5;136(17):2113-2115. doi: 10.1097/CM9.0000000000002597.

Authors

Mengmeng Xiao^{1

2}, Xiaobing Chen^{1

2}, Weida Chen^{1

2}, Lihua Wang^{2

3}, Xiaosong Rao^{2

3}, Chenghua Luo^{1

2}

Affiliations

¹ Department of Retroperitoneal Tumor Surgery, Peking University International Hospital, Beijing 102206, China.
² The Eighth Clinical College of Peking University, Beijing 100080, China.
³ Department of Pathology, Peking University International Hospital, Beijing 102206, China.

No abstract available

MeSH terms

Calcium-Binding Proteins
Humans
Liposarcoma*
Membrane Proteins
Mixed Function Oxygenases
Muscle Proteins
Retroperitoneal Neoplasms*

Substances

ASPH protein, human
Calcium-Binding Proteins
Mixed Function Oxygenases
Membrane Proteins
Muscle Proteins

Supplementary concepts

Retroperitoneal liposarcoma